ELIAS Animal Health is a medical biotechnology company advancing its novel targeted T cell-based immunotherapies for the treatment of canine cancers. It develops the ELIAS cancer immunotherapy (ECI), an autologous prescription product, which harnesses the power of the dog’s own immune system to eliminate cancer.